Skip to main content

The Standard for Clinicians’ Interview in Psychiatry (SCIP) as an Assessment Tool for Personalized Medicine in Psychiatry

  • Chapter
  • First Online:
Manual for the Standard for Clinicians’ Interview in Psychiatry (SCIP)

Part of the book series: Advances in Mental Health and Addiction ((AMHA))

Abstract

Personalized Medicine in Psychiatry (PMP) is the science of the systematic use of individual characteristics across four domains (life story, environmental factors, psychopathology assessment, and translational neuroscience findings [e.g., brain imaging, genomics, pharmacogenomics, biomarkers, endophenotypes, or any newly developed technique or blood test]) to guide the clinician toward a person-centered diagnosis, person-centered prognosis, and person-centered therapeutics (e.g., personalized selection and personalized dosing of medications). The clinician’s ultimate goal is to improve the outcome of the disease, and eventually to prevent the disease. Each of the SCIP’s 30 screening items and 200 psychopathology items has a unique PMP code. Chapter 11 demonstrates how to use the SCIP as a new PMP assessment tool. Case demonstrations are also be shown.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 119.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 159.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 159.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Wium-Andersen, I. K., Vinberg, M., Kessing, L. V., & McIntyre, R. S. (2017). Personalized medicine in psychiatry. Nordic Journal of Psychiatry, 71, 12–19.

    Article  PubMed  Google Scholar 

  2. Domschke, K., Muller, D. J., & Serretti, A. (2015). Personalized therapies in psychiatry: Promises, pitfalls and perspectives. Journal of Neural Transmission, 122, 1–3.

    Article  PubMed  Google Scholar 

  3. Hong, D. S. (2014). Here/in this issue and there/abstract thinking: Personalized psychiatry: Are we almost there? Journal of the American Academy of Child and Adolescent Psychiatry, 53, 263–264.

    Article  PubMed  Google Scholar 

  4. Kessler, R. C., McLaughlin, K. A., Green, J. G., Gruber, M. J., Sampson, N. A., Zaslavsky, A. M., Aguilar-Gaxiola, S., Alhamzawi, A. O., Alonso, J., Angermeyer, M., Benjet, C., Bromet, E., Chatterji, S., de Girolamo, G., Demyttenaere, K., Fayyad, J., Florescu, S., Gal, G., Gureje, O., … Williams, D. R. (2010). Childhood adversities and adult psychopathology in the WHO World Mental Health Surveys. The British Journal of Psychiatry: The Journal of Mental Science, 197, 378–385.

    Article  Google Scholar 

  5. Varese, F., Smeets, F., Drukker, M., Lieverse, R., Lataster, T., Viechtbauer, W., Read, J., van Os, J., & Bentall, R. P. (2012). Childhood adversities increase the risk of psychosis: A meta-analysis of patient-control, prospective- and cross-sectional cohort studies. Schizophrenia Bulletin, 38, 661–671.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Sonnby, K., Aslund, C., Leppert, J., & Nilsson, K. W. (2011). Symptoms of ADHD and depression in a large adolescent population: Co-occurring symptoms and associations to experiences of sexual abuse. Nordic Journal of Psychiatry, 65, 315–322.

    Article  PubMed  Google Scholar 

  7. Weber, K., Rockstroh, B., Borgelt, J., Awiszus, B., Popov, T., Hoffmann, K., Schonauer, K., Watzl, H., & Propster, K. (2008). Stress load during childhood affects psychopathology in psychiatric patients. BMC Psychiatry, 8, 63.

    Article  PubMed  PubMed Central  Google Scholar 

  8. Peterson, B. S. (2020). Editorial: Biomarkers in precision medicine for mental illnesses. Journal of Child Psychology and Psychiatry, 61, 1279–1281.

    Article  PubMed  Google Scholar 

  9. Manchia, M., Pisanu, C., Squassina, A., & Carpiniello, B. (2020). Challenges and future prospects of precision medicine in psychiatry. Pharmacogenomics and Personalized Medicine, 13, 127–140.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Krueger, R. F., & Bezdjian, S. (2009). Enhancing research and treatment of mental disorders with dimensional concepts: Toward DSM-V and ICD-11. World Psychiatry, 8, 3–6.

    Article  PubMed  PubMed Central  Google Scholar 

  11. Biomarkers Definitions Working Group. (2001). Biomarkers and surrogate endpoints: Preferred definitions and conceptual framework. Clinical Pharmacology & Therapeutics, 69, 89–95.

    Article  Google Scholar 

  12. Keshavan, M. S. (2013). Classification of psychotic disorders: Need to move toward a neuroscience-informed nosology. Asian Journal of Psychiatry, 6, 191–192.

    Article  PubMed  Google Scholar 

  13. Keshavan, M. S. (2013). Nosology of psychoses in DSM-5: Inches ahead but miles to go. Schizophrenia Research, 150, 40–41.

    Article  PubMed  Google Scholar 

  14. Kendler, K. S. (2009). An historical framework for psychiatric nosology. Psychological Medicine, 39, 1935–1941.

    Article  PubMed  PubMed Central  Google Scholar 

  15. National Research Council. (2011). Toward precision medicine: Building a knowledge network for biomedical research and a new taxonomy of disease. National Research Council.

    Google Scholar 

  16. Cuthbert, B. N. (2014). The RDoC framework: Facilitating transition from ICD/DSM to dimensional approaches that integrate neuroscience and psychopathology. World Psychiatry, 13, 28–35.

    Article  PubMed  PubMed Central  Google Scholar 

  17. Insel, T., Cuthbert, B., Garvey, M., Heinssen, R., Pine, D. S., Quinn, K., Sanislow, C., & Wang, P. (2010). Research domain criteria (RDoC): Toward a new classification framework for research on mental disorders. The American Journal of Psychiatry, 167, 748–751.

    Article  PubMed  Google Scholar 

  18. Keshavan, M. S., Tandon, R., & Nasrallah, H. A. (2013). Renaming schizophrenia: Keeping up with the facts. Schizophrenia Research, 148, 1–2.

    Article  CAS  PubMed  Google Scholar 

  19. Stoyanov, D. S. (2017). Key developments in translational neuroscience: An update. Balkan Medical Journal, 34, 485–486.

    Article  PubMed  PubMed Central  Google Scholar 

  20. Aragona, M. (2017). The impact of translational neuroscience on revisiting psychiatric diagnosis: State of the art and conceptual analysis. Balkan Medical Journal, 34, 487–492.

    Article  PubMed  PubMed Central  Google Scholar 

  21. Lilienfeld, S. O. (2014). The Research Domain Criteria (RDoC): An analysis of methodological and conceptual challenges. Behaviour Research and Therapy, 62, 129–139.

    Article  PubMed  Google Scholar 

  22. Carroll, B. J. (2015). Clinical science and biomarkers: Against RDoC. Acta Psychiatrica Scandinavica, 132, 423–424.

    Article  CAS  PubMed  Google Scholar 

  23. Chang, H. (2004). Inventing temperature: Measurement and scientific progress. Oxford University Press.

    Book  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

Copyright information

© 2022 The Author(s), under exclusive license to Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Aboraya, A.S. (2022). The Standard for Clinicians’ Interview in Psychiatry (SCIP) as an Assessment Tool for Personalized Medicine in Psychiatry. In: Manual for the Standard for Clinicians’ Interview in Psychiatry (SCIP). Advances in Mental Health and Addiction. Springer, Cham. https://doi.org/10.1007/978-3-030-94930-3_11

Download citation

Publish with us

Policies and ethics